CF
DXCM icon

Covea Finance’s DexCom DXCM Stock Holding History

Covea Finance’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-111,200
Closed -$9.71M – 124
2025
Q2 		$9.71M Buy
111,200
+27,300
+33% +$2.14M 0.36% 71
2025
Q1 		$5.73M Sell
83,900
-147,910
-64% -$12.1M 0.26% 76
2024
Q4 		$18M Hold
231,810
– – 0.81% 39
2024
Q3 		$15.5M Sell
231,810
-21,700
-9% -$1.78M 0.68% 45
2024
Q2 		$28.7M Buy
253,510
+5,570
+2% +$704K 1.32% 25
2024
Q1 		$34.4M Sell
247,940
-6,000
-2% -$754K 1.62% 20
2023
Q4 		$31.5M Buy
253,940
+4,100
+2% +$419K 1.54% 26
2023
Q3 		$23.3M Buy
249,840
+96,940
+63% +$10.9M 1.31% 34
2023
Q2 		$19.6M Buy
+152,900
New +$18.5M 1.07% 41

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Covea Finance's DXCM Position: Q3 2025 in Review

Covea Finance sold out of DexCom (DXCM) in Q3 2025, closing a stake of 111,200 shares — an estimated $9.71M sold.

Covea Finance first reported a position in DXCM in Q2 2023 and held it in 9 quarters. The position peaked at $34.4M in Q1 2024. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Covea Finance reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Covea Finance sold 111,200 DexCom shares in Q3 2025, an estimated $9.71M.
  • Covea Finance first reported a position in DexCom in Q2 2023 and held it in 9 quarters.
  • Covea Finance's DexCom position peaked at $34.4M in Q1 2024.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Covea Finance's 13F filing for Q3 2025, filed 16 Oct 2025.